z-logo
Premium
Piperacillin–tazobactam‐induced linear IgA bullous dermatosis presenting clinically as Stevens–Johnson syndrome/toxic epidermal necrolysis overlap
Author(s) -
Adler N. R.,
McLean C. A.,
Aung A. K.,
Goh M. S. Y.
Publication year - 2017
Publication title -
clinical and experimental dermatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.587
H-Index - 78
eISSN - 1365-2230
pISSN - 0307-6938
DOI - 10.1111/ced.13030
Subject(s) - toxic epidermal necrolysis , dermatology , medicine , piperacillin/tazobactam , piperacillin , tazobactam , biology , bacteria , pseudomonas aeruginosa , genetics
Summary Linear IgA bullous dermatosis ( LABD ) is a subepidermal autoimmune bullous disease characterized by linear IgA deposition at the basement membrane zone, which is visualized by direct immunofluorescence. Patients with LABD typically present with widespread vesicles and bullae; however, this is not necessarily the case, as the clinical presentation of this disease is heterogeneous. LABD clinically presenting as Stevens–Johnson syndrome ( SJS ) or toxic epidermal necrolysis ( TEN ) is an infrequent, yet well‐described phenomenon. Most cases of LABD are idiopathic, but some cases are drug‐induced. Multiple drugs have been implicated in the development of LABD . We report a case of piperacillin–tazobactam‐induced LABD presenting clinically as SJS / TEN overlap. This is the first reported case of a strong causal association between piperacillin‐tazobactam and the development of LABD .

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom